← SynDRA
BAG956
SynDRA canonical compound SYN1951538 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | PDPK1 | PIK3CG |
|---|
| Mechanism of action | phosphoinositide dependent kinase inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- phosphoinositide dependent kinase inhibitor
- PIK3CG INHIBITOR
Cross-references
Synonyms
- NVP-BAG956
- BAG-956
- NVP-BAG956(BAG 956)
- UNII-4UFC2K6E50
- 4UFC2K6E50
- 2-Methyl-2-(4-(2-methyl-8-((pyridin-3-yl)ethynyl)imidazo(4,5-C)quinolin-1-yl)phenyl)propionitrile
- 2-methyl-2-(4-(2-methyl-8-(pyridin-3-ylethynyl)-1H-imidazo[4,5-c]quinolin-1-yl)phenyl)propanenitrile
- 2-Methyl-2-{4-[2-methyl-8-(pyridin-3-ylethynyl)-1H-imidazo[4,5-c]quinolin-1-yl]phenyl}propanenitrile
- 2-Methyl-2-[4-[2-methyl-8-[(pyridin-3-yl)ethynyl]imidazo[4,5-c]quinolin-1-yl]phenyl]propionitrile
- NVP-BAG-956
Look up BAG956 in the interactive SynDRA portal →